| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS124466 | Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment | 000 | 2 | NIH | 12/18/2023 | $0 |
| | 2024 | 2022 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS122700 | Prolactin monoclonal antibodies (PRL-mAbs) for the treatment of female-predominant pain syndromes | 000 | 2 | NIH | 2/22/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS127786 | Peptide-antibody conjugate kappa-opioid receptor (PAC-KOR) agonists for treatment of chronic itch | 000 | 1 | NIH | 7/14/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $898,189 ) |
| | 2022 | 2022 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS124466 | Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment | 000 | 2 | NIH | 8/18/2022 | $199,432 |
| | 2022 | 2022 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS122700 | Prolactin monoclonal antibodies (PRL-mAbs) for the treatment of female-predominant pain syndromes | 000 | 2 | NIH | 6/14/2022 | $199,308 |
| | 2022 | 2022 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS127786 | Peptide-antibody conjugate kappa-opioid receptor (PAC-KOR) agonists for treatment of chronic itch | 000 | 1 | NIH | 8/5/2022 | $499,449 |
| | 2022 | 2020 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44NS119770 | Peripherally-Restricted Long-Acting Somatostatin Receptor 4 (LA-SSTR4) Agonists for Pain | 000 | 3 | NIH | 8/8/2022 | $0 |
| | 2022 | 2019 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA042634 | Peripherally-restricted and long-acting kappa-opioid receptor (LA-KOR) agonists for pain | 000 | 3 | NIH | 12/7/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $995,901 ) |
| | 2021 | 2021 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS124466 | Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment | 001 | 1 | NIH | 9/10/2021 | $0 |
| | 2021 | 2021 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS124466 | Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment | 000 | 1 | NIH | 9/8/2021 | $499,290 |
| | 2021 | 2021 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43NS122700 | Prolactin monoclonal antibodies (PRL-mAbs) for the treatment of female-predominant pain syndromes | 000 | 1 | NIH | 6/25/2021 | $496,611 |
|
| Issue Date FY: 2020 ( Subtotal = $1,410,027 ) |
| | 2020 | 2020 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44NS119770 | Peripherally-Restricted Long-Acting Somatostatin Receptor 4 (LA-SSTR4) Agonists for Pain | 000 | 3 | NIH | 8/4/2020 | $1,410,027 |
| | 2020 | 2019 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA045410 | Peripherally-Restricted Long-Acting Somatostatin Receptor 4 (LA-SSTR4) Agonists for Pain | 001 | 2 | NIH | 2/26/2020 | $0 |
| | 2020 | 2019 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA045410 | Peripherally-Restricted Long-Acting Somatostatin Receptor 4 (LA-SSTR4) Agonists for Pain | 000 | 2 | NIH | 11/22/2019 | $0 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 002 | 1 | NIH | 4/13/2020 | -$18,550 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 000 | 1 | NIH | 11/13/2019 | $0 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 003 | 1 | NIH | 4/14/2020 | $18,550 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 004 | 1 | NIH | 4/14/2020 | $18,550 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 001 | 1 | NIH | 4/13/2020 | -$18,550 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 006 | 1 | NIH | 5/6/2020 | -$18,550 |
| | 2020 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 005 | 1 | NIH | 5/6/2020 | $18,550 |
|
| Issue Date FY: 2019 ( Subtotal = $3,364,557 ) |
| | 2019 | 2019 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA042634 | Peripherally-restricted and long-acting kappa-opioid receptor (LA-KOR) agonists for pain | 000 | 3 | NIH | 7/12/2019 | $1,431,363 |
| | 2019 | 2019 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA047722 | Peripherally-restricted and long-acting MAS1(LA-MAS1) agonists for pain | 000 | 1 | NIH | 3/4/2019 | $347,799 |
| | 2019 | 2019 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA045410 | Peripherally-Restricted Long-Acting Somatostatin Receptor 4 (LA-SSTR4) Agonists for Pain | 000 | 2 | NIH | 9/23/2019 | $1,585,395 |
| | 2019 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 000 | 1 | NIH | 12/14/2018 | $0 |
| | 2019 | 2017 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43GM125406 | Bi-Functional Peptides to Block Vasodilation and Vascular Leakage in Sepsis | 000 | 1 | NIH | 5/15/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $2,064,299 ) |
| | 2018 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 000 | 1 | NIH | 12/13/2017 | $279,411 |
| | 2018 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 001 | 1 | NIH | 12/14/2017 | $0 |
| | 2018 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 002 | 1 | NIH | 8/1/2018 | $0 |
| | 2018 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA045410 | PERIPHERALLY-RESTRICTED LONG-ACTING SOMATOSTATIN RECEPTOR TYPE 4 (LA-SSTR4) AGONISTS FOR PAIN | 003 | 1 | NIH | 9/10/2018 | $260,861 |
| | 2018 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA042634 | Peripherally-restricted and long-acting kappa-opioid receptor (LA-KOR) agonists for pain | 000 | 2 | NIH | 7/31/2018 | $1,524,027 |
| | 2018 | 2018 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R44DA042634 | Peripherally-restricted and long-acting kappa-opioid receptor (LA-KOR) agonists for pain | 001 | 2 | NIH | 9/20/2018 | $0 |
| | 2018 | 2016 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43DA042634 | Long-Acting Peripherally-Restricted Peptidic Kappa Opioid Receptor Agonists for Pain | 000 | 1 | NIH | 12/4/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $298,121 ) |
| | 2017 | 2017 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130-2642 | SAN DIEGO | USA | R43GM125406 | Bi-Functional Peptides to Block Vasodilation and Vascular Leakage in Sepsis | 000 | 1 | NIH | 8/24/2017 | $298,121 |
|
| Issue Date FY: 2016 ( Subtotal = $206,927 ) |
| | 2016 | 2016 | PEPTIDE LOGIC LLC | 3993 VIA CANGREJO | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | R43DA042634 | Long-Acting Peripherally-Restricted Peptidic Kappa Opioid Receptor Agonists for Pain | 000 | 1 | NIH | 7/5/2016 | $206,927 |
|
|
